PTK2 and hepatocellular carcinoma: Given this, genistein, by downregulating p125FAK, inhibited the metastatic activity of hepatocellular carcinoma (HCC) cells (Bel 7402) coupled with angiogenesis suppression in a murine xenograft model [90].